Importantly, DB combined with a dual blockade of TIGIT and PD-L1 resulted in an almost complete eradication of the tumors and the highest OS probabilities, even under resistant conditions, thus representing a very promising treatment strategy against high-risk NB. The gene discussed is CD274; the disease is neuroblastoma.